638 related articles for article (PubMed ID: 30670047)
1. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
3. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
[TBL] [Abstract][Full Text] [Related]
4. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
[TBL] [Abstract][Full Text] [Related]
5. TLR4
Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
7. Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus.
Ren J; Catalina MD; Eden K; Liao X; Read KA; Luo X; McMillan RP; Hulver MW; Jarpe M; Bachali P; Grammer AC; Lipsky PE; Reilly CM
Front Immunol; 2019; 10():2512. PubMed ID: 31708928
[TBL] [Abstract][Full Text] [Related]
8. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
9. Thymic B Cells Promote Germinal Center-Like Structures and the Expansion of Follicular Helper T Cells in Lupus-Prone Mice.
Hidalgo Y; Núñez S; Fuenzalida MJ; Flores-Santibáñez F; Sáez PJ; Dorner J; Lennon-Dumenil AM; Martínez V; Zorn E; Rosemblatt M; Sauma D; Bono MR
Front Immunol; 2020; 11():696. PubMed ID: 32411134
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
11. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
12. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
Davison LM; Jørgensen TN
Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus.
Lee J; Shin EK; Lee SY; Her YM; Park MK; Kwok SK; Ju JH; Park KS; Kim HY; Cho ML; Park SH
Immunology; 2014 Aug; 142(4):573-80. PubMed ID: 24495300
[TBL] [Abstract][Full Text] [Related]
16. [Study on experimental systemic lupus erythematosus mouse model induced by pristane].
Li JZ; Ding J; Merim B; Li HW; Zhang Y; Shen H; Chen XJ; Wang SJ; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):119-22. PubMed ID: 21315035
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
Chae BS; Shin TY
Arch Pharm Res; 2007 Feb; 30(2):191-8. PubMed ID: 17366741
[TBL] [Abstract][Full Text] [Related]
18. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol possesses protective effects in a pristane-induced lupus mouse model.
Wang ZL; Luo XF; Li MT; Xu D; Zhou S; Chen HZ; Gao N; Chen Z; Zhang LL; Zeng XF
PLoS One; 2014; 9(12):e114792. PubMed ID: 25501752
[TBL] [Abstract][Full Text] [Related]
20. Patterns of ANA+ B cells for SLE patient stratification.
Suurmond J; Atisha-Fregoso Y; Barlev AN; Calderon SA; Mackay MC; Aranow C; Diamond B
JCI Insight; 2019 May; 4(9):. PubMed ID: 31045579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
